hypertension - Nursing Case Study
Pathophysiology
• Primary mechanism: Increased systemic vascular resistance due to chronic vasoconstriction, largely influenced by elevated sympathetic nervous system activity and dysregulated renin-angiotensin-aldosterone system (RAAS), which leads to persistent narrowing of blood vessels and increased blood pressure.
• Secondary mechanism: Structural remodeling of blood vessels, including endothelial dysfunction and vascular hypertrophy, which further exacerbate vessel stiffness and resistance, perpetuating high blood pressure and reducing responsiveness to vasodilatory signals.
• Key complication: Persistent hypertension accelerates cardiovascular complications, such as left ventricular hypertrophy, heart failure, and increased risk of ischemic stroke, due to the heart's prolonged effort to overcome elevated peripheral resistance and maintain adequate perfusion.
Patient Profile
Demographics:
58-year-old male, retired construction worker
History:
• Key past medical history: Long-standing hypertension, type 2 diabetes mellitus, chronic kidney disease stage 3, history of myocardial infarction
• Current medications: Lisinopril, Metformin, Aspirin, Atorvastatin, Amlodipine
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe headache and dizziness
• Key symptoms: Shortness of breath, chest pain, visual disturbances, fatigue
• Vital signs: Blood pressure 210/130 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 90% on room air
Section 1
As the healthcare team rapidly assesses the patient, initial findings reveal significant abnormalities. The physical examination identifies notable bilateral rales upon auscultation of the lungs, suggesting pulmonary congestion. Jugular venous distention is observed, indicating increased central venous pressure, which is consistent with cardiac involvement. The patient's extremities are cool to the touch, and peripheral pulses are weak, reflecting compromised peripheral circulation. Neurological assessment shows altered mental status with confusion and difficulty focusing, raising concerns about potential cerebral hypoperfusion or hypertensive encephalopathy.
Laboratory results further clarify the patient's status and contribute to the clinical picture. Serum creatinine is elevated at 2.3 mg/dL, indicating worsening renal function, possibly due to acute kidney injury superimposed on chronic kidney disease. Blood glucose levels are elevated at 240 mg/dL, suggesting poor glycemic control, which can exacerbate vascular complications. Cardiac biomarkers reveal a mild elevation in troponin I, raising the possibility of ongoing myocardial ischemia or demand ischemia due to the severe hypertension. Electrolyte imbalances are also present, with hypokalemia noted, likely a consequence of the RAAS activation and diuretic use.
In response to the critical state, immediate interventions are initiated. The patient is started on intravenous nitroglycerin to achieve rapid blood pressure reduction and alleviate cardiac workload. Continuous cardiac monitoring is established to detect any arrhythmias or ischemic changes. Oxygen therapy is administered to improve oxygen saturation and relieve dyspnea. The healthcare team must now anticipate potential complications such as acute decompensated heart failure or hypertensive crisis, necessitating vigilant monitoring and potential escalation of care. The unfolding scenario demands advanced clinical reasoning to balance hemodynamic stabilization with the risks of rapid blood pressure correction, ensuring that organ perfusion is preserved while mitigating further end-organ damage.
Section 2
As the healthcare team continues to monitor the patient's response to the initial interventions, new diagnostic results become available, offering further insight into the patient's complex condition. An echocardiogram is performed, revealing a significantly reduced ejection fraction of 35%, consistent with systolic heart failure. There is evidence of left ventricular hypertrophy, further supporting the chronicity of the patient's hypertensive disease. Additionally, a chest X-ray confirms bilateral pulmonary edema, correlating with the auscultation findings and indicating significant fluid overload.
Lab results show a further decline in renal function, with serum creatinine rising to 2.8 mg/dL, suggesting ongoing acute kidney injury likely exacerbated by reduced renal perfusion and possible nephrotoxic effects from medications. The patient's electrolyte imbalance persists, with potassium levels dropping to 3.0 mEq/L despite supplementation, necessitating careful adjustment of diuretics and the introduction of potassium-sparing agents. A repeat troponin test shows a slight increase, raising concerns about potential myocardial infarction or continued cardiac strain.
Despite the interventions, the patient's blood pressure remains elevated at 180/110 mmHg, and heart rate has increased to 115 bpm. The patient exhibits increased restlessness and agitation, suggesting worsening cerebral effects, possibly due to hypertensive encephalopathy or ongoing ischemia. This change necessitates a reassessment of the therapeutic strategy, considering the addition of alternative antihypertensive agents such as beta-blockers or ACE inhibitors, with careful titration to avoid precipitous drops in blood pressure. The team faces the challenge of balancing aggressive management of hypertension with the risk of worsening renal function and cerebral perfusion, requiring precise clinical judgment and the anticipation of further complications.
Section 3
As the healthcare team continues to navigate the complexities of the patient's condition, a critical change in status is observed. The patient's restlessness escalates into confusion and disorientation, raising immediate concerns about neurological compromise. Neurological assessment reveals a Glasgow Coma Scale (GCS) score that has dropped to 12, with notable difficulty in maintaining attention and orientation. The patient's pupils are equal and reactive, but there is a noticeable delay in response. Given the suspicion of hypertensive encephalopathy, an urgent CT scan of the head is ordered to rule out possible cerebral edema or hemorrhage.
Concurrently, the patient's respiratory status deteriorates. Despite supplemental oxygen, the patient is now tachypneic with a respiratory rate of 28 breaths per minute, and oxygen saturation has fallen to 88% on a non-rebreather mask. Auscultation of the lungs reveals coarse crackles extending throughout both lung fields, indicating worsening pulmonary congestion. Arterial blood gas analysis shows a pH of 7.32, PaCO2 of 50 mmHg, and PaO2 of 60 mmHg, suggestive of acute respiratory acidosis and hypoxemia. These findings necessitate immediate respiratory support, and the decision is made to initiate BiPAP therapy to improve ventilation and oxygenation.
The clinical team is now confronted with the urgent need to stabilize the patient while addressing the underlying pathophysiology. A nephrology consult is requested to evaluate the deteriorating renal function, considering potential renal replacement therapy options. Meanwhile, cardiology re-evaluates the medication regimen, considering the addition of an intravenous nitroglycerin infusion to manage the resistant hypertension and alleviate cardiac strain, with the goal of improving the patient's hemodynamics without compromising renal perfusion. This multifaceted approach underscores the critical need for coordinated, interdisciplinary care to navigate the patient's complex and evolving condition.
Section 4
As the healthcare team implements the BiPAP therapy, there is a modest improvement in the patient's oxygenation, with oxygen saturation rising to 92%, though the respiratory rate remains elevated at 26 breaths per minute. However, the neurological status continues to deteriorate. The patient exhibits increasing restlessness, now coupled with episodes of brief, involuntary muscle twitching, raising suspicions of seizure activity. Neurology is consulted urgently, and an electroencephalogram (EEG) is ordered to assess for possible subclinical seizures, a complication likely associated with hypertensive encephalopathy. The CT scan results return, revealing diffuse cerebral edema without evidence of intracerebral hemorrhage, corroborating the suspected diagnosis of hypertensive encephalopathy.
Concurrently, the nephrology consult reveals significant deterioration in renal function, with serum creatinine levels rising to 3.5 mg/dL and blood urea nitrogen (BUN) at 85 mg/dL, indicating acute kidney injury potentially exacerbated by the patient's uncontrolled hypertension. In light of this, the nephrology team considers the initiation of continuous renal replacement therapy (CRRT) to manage fluid overload and support renal function, especially given the patient's refractory pulmonary congestion. The cardiology team adjusts the nitroglycerin infusion to carefully titrate the patient's blood pressure, aiming for gradual reduction to avoid exacerbating cerebral perfusion compromise.
The patient's complex condition necessitates a seamless collaboration among the multidisciplinary team, with close monitoring of neurological, respiratory, renal, and cardiovascular parameters. Despite the interventions, the patient remains in a precarious balance, with potential for further complications such as progression to status epilepticus or the need for mechanical ventilation if respiratory support becomes inadequate. The team remains vigilant, ready to adapt the treatment plan as new data emerges, emphasizing the critical importance of dynamic clinical reasoning in managing this intricate case.
Section 5
As the clinical team continues to closely monitor the patient, there is a noted change in the patient's status overnight. The patient's blood pressure remains labile despite the carefully titrated nitroglycerin infusion, fluctuating between 160/100 mmHg and 180/110 mmHg. This instability raises concerns about ongoing hypertensive crises, potentially exacerbating cerebral and renal complications. The nursing team reports that the patient has become increasingly lethargic, with a Glasgow Coma Scale (GCS) score dropping to 10, prompting a reevaluation of the current management strategy.
New diagnostic results from the EEG confirm the presence of intermittent subclinical seizure activity, necessitating the initiation of antiepileptic therapy. The neurology team recommends starting intravenous levetiracetam to control seizure activity and prevent progression to status epilepticus. Meanwhile, arterial blood gas analysis reveals a worsening metabolic acidosis, with a pH of 7.28, bicarbonate 18 mEq/L, and a base deficit of -8, likely related to both renal impairment and respiratory distress. This prompts the nephrology team to expedite the start of continuous renal replacement therapy to address the acid-base imbalance and fluid overload.
Faced with these developments, the critical care team must reassess the patient's overall treatment plan. The balance between managing hypertension, controlling seizures, and supporting failing organ systems remains delicate. The intensivist considers the potential need for mechanical ventilation if the patient's respiratory effort continues to decline, while also contemplating the introduction of additional antihypertensive agents to achieve more stable blood pressure control. The multidisciplinary team remains on high alert, prepared to swiftly implement further interventions as the patient's condition evolves, highlighting the complexity and dynamic nature of managing severe hypertensive emergencies with multi-organ involvement.